Abbot AxSYM
This article was originally published in The Gray Sheet
Executive Summary
Hepatitis C virus microparticle enzyme immunoassay is approvable for the qualitative detection of HCV antibody in human serum or plasma, FDA's Microbiology Devices Panel unanimously (7-0) recommends Jan. 21. However, labeling must include a "clear and prominent" statement that confirmatory testing should occur after a positive result, as well as data tables showing test patient populations to explain the origin of the clinical testing results, panel says
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.